Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has outperformed its main competitor, Wegovy, in a clinical trial funded by Lilly. “Given the increased interest around obesity medications, we conducted this study to help health care providers and patients make informed decisions about treatment choice,” Dr. Leonard Glass, senior vice president of…  read on >  read on >

Taking even high doses of supplementary vitamin D won’t lower an older person’s odds for type 2 diabetes, new research confirms. Vitamin D supplements may have other benefits, but in otherwise healthy folks with sufficient levels of the nutrient, “our findings do not suggest benefits of long-term moderate- or high-dose vitamin D3 supplementation” in warding off…  read on >  read on >

Sixty-eight people have been sickened and 18 have been hospitalized in a salmonella outbreak linked to whole cucumbers sold in 26 states and parts of Canada. “Epidemiologic and traceback information shows that cucumbers grown by Agrotato, S.A. de C.V. in Sonora, Mexico, including recalled cucumbers from SunFed Produce LLC, may be contaminated with salmonella and may be…  read on >  read on >

MONDAY, Dec.2, 2024Cases of inflammatory bowel disease (IBD) are rising at an alarming rate among young Americans, a new study reveals. “Prevalence rates [are] among the highest reported worldwide,” said researcher Dr. Michael Kappelman, a professor of pediatrics and epidemiology at the University of North Carolina at Chapel Hill.  The study — published Nov. 20…  read on >  read on >